Literature DB >> 16301673

Protein kinase Ctheta controls Th1 cells in experimental autoimmune encephalomyelitis.

Shahram Salek-Ardakani1, Takanori So, Beth S Halteman, Amnon Altman, Michael Croft.   

Abstract

Molecules that regulate encephalitogenic T cells are of interest for multiple sclerosis. In this study we show that protein kinase Ctheta (PKCtheta) is critical for the development of Ag-specific Th1 cells in experimental allergic encephalomyelitis (EAE), a model of multiple sclerosis. PKCtheta-deficient mice immunized with myelin oligodendrocyte glycoprotein failed to develop cell infiltrates and Th1 cytokines in the CNS and were resistant to the development of clinical EAE. CD4 T cells became primed and accumulated in secondary lymphoid organs in the absence of PKCtheta, but had severely diminished IFN-gamma, TNF, and IL-17 production. Increasing Ag exposure and inflammatory conditions failed to induce EAE in PKCtheta-deficient mice, showing a profound defect in the myelin oligodendrocyte glycoprotein-reactive T cell population. These data provide evidence of a pivotal role for PKCtheta in the generation and effector function of autoimmune Th1 cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16301673     DOI: 10.4049/jimmunol.175.11.7635

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  43 in total

Review 1.  PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejection.

Authors:  Myung-Ja Kwon; Ruiqing Wang; Jian Ma; Zuoming Sun
Journal:  Endocr Metab Immune Disord Drug Targets       Date:  2010-12       Impact factor: 2.895

2.  Structural determinants of phorbol ester binding activity of the C1a and C1b domains of protein kinase C theta.

Authors:  Agnes Czikora; Satyabrata Pany; Youngki You; Amandeep S Saini; Nancy E Lewin; Gary A Mitchell; Adelle Abramovitz; Noemi Kedei; Peter M Blumberg; Joydip Das
Journal:  Biochim Biophys Acta Biomembr       Date:  2018-01-06       Impact factor: 3.747

3.  Protein kinase C-θ inhibits inducible regulatory T cell differentiation via an AKT-Foxo1/3a-dependent pathway.

Authors:  Jian Ma; Yan Ding; Xianfeng Fang; Ruiqing Wang; Zuoming Sun
Journal:  J Immunol       Date:  2012-04-25       Impact factor: 5.422

4.  Protective Toxoplasma gondii-specific T-cell responses require T-cell-specific expression of protein kinase C-theta.

Authors:  Gopala Nishanth; Monika Sakowicz-Burkiewicz; Ulrike Händel; Stefanie Kliche; Xiaoqian Wang; Michael Naumann; Martina Deckert; Dirk Schlüter
Journal:  Infect Immun       Date:  2010-05-24       Impact factor: 3.441

Review 5.  The yin and yang of protein kinase C-theta (PKCθ): a novel drug target for selective immunosuppression.

Authors:  Elizabeth Yan Zhang; Kok-Fai Kong; Amnon Altman
Journal:  Adv Pharmacol       Date:  2013

6.  Protein kinase C-theta is required for development of experimental cerebral malaria.

Authors:  Mathilde Fauconnier; Marie-Laure Bourigault; Sandra Meme; Frederic Szeremeta; Jennifer Palomo; Adeline Danneels; Sabine Charron; Lizette Fick; Muazzam Jacobs; Jean-Claude Beloeil; Bernhard Ryffel; Valerie F J Quesniaux
Journal:  Am J Pathol       Date:  2010-12-23       Impact factor: 4.307

7.  A critical role for protein kinase C-theta-mediated T cell survival in cardiac allograft rejection.

Authors:  Santhakumar Manicassamy; Dengping Yin; Zheng Zhang; Luciana L Molinero; Marisa-Luisa Alegre; Zuoming Sun
Journal:  J Immunol       Date:  2008-07-01       Impact factor: 5.422

8.  PKCtheta is required for alloreactivity and GVHD but not for immune responses toward leukemia and infection in mice.

Authors:  Javier O Valenzuela; Cristina Iclozan; Mohammad S Hossain; Martin Prlic; Emily Hopewell; Crystina C Bronk; Junmei Wang; Esteban Celis; Robert W Engelman; Bruce R Blazar; Michael J Bevan; Edmund K Waller; Xue-Zhong Yu; Amer A Beg
Journal:  J Clin Invest       Date:  2009-11-09       Impact factor: 14.808

Review 9.  In and out of the bull's eye: protein kinase Cs in the immunological synapse.

Authors:  Kok-Fai Kong; Amnon Altman
Journal:  Trends Immunol       Date:  2013-02-19       Impact factor: 16.687

10.  Prediction of PKCθ inhibitory activity using the Random Forest Algorithm.

Authors:  Ming Hao; Yan Li; Yonghua Wang; Shuwei Zhang
Journal:  Int J Mol Sci       Date:  2010-09-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.